Carrie Krehlik
Ufficiale delle Risorse Umane presso Adicet Therapeutics, Inc.
Profilo
Carrie Krehlik is currently the Chief Human Resource Officer & Senior VP at Adicet Therapeutics, Inc. She previously held the same position at Adicet Bio, Inc. from 2017 to 2021.
Prior to that, she was the Chief Human Resources Officer at Global Blood Therapeutics, Inc. from 2021 to 2022.
She also served as Vice President-Human Resources at InterMune, Inc. from 2012 to 2015 and at ZS Pharma, Inc. from 2015 to 2016.
Additionally, she was the Chief Human Resources Officer & Senior VP at resTORbio, Inc. She received an undergraduate degree from Miami University and an MBA from San Francisco State University.
Posizioni attive di Carrie Krehlik
Società | Posizione | Inizio |
---|---|---|
Adicet Therapeutics, Inc.
Adicet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Adicet Therapeutics, Inc. operates as a biopharmaceutical company focuses on the development of cell immunotherapies. It engages in the design and development of immunotherapies for cancer and other disease indications with a focus on novel universal immune cell therapies. The company was founded by Aya Jakobovits in 2014 and is headquartered in Beverly Hills, CA. | Ufficiale delle Risorse Umane | 01/11/2017 |
Precedenti posizioni note di Carrie Krehlik
Società | Posizione | Fine |
---|---|---|
GLOBAL BLOOD THERAPEUTICS, INC. | Ufficiale delle Risorse Umane | 01/12/2022 |
ADICET BIO, INC. | Ufficiale delle Risorse Umane | 01/05/2021 |
ZS PHARMA INC | Ufficiale delle Risorse Umane | 01/06/2016 |
INTERMUNE INC | Ufficiale delle Risorse Umane | 01/03/2015 |
ADICET BIO, INC. | Ufficiale delle Risorse Umane | - |
Formazione di Carrie Krehlik
Miami University | Undergraduate Degree |
San Francisco State University | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
ADICET BIO, INC. | Health Technology |
Aziende private | 5 |
---|---|
resTORbio, Inc.
resTORbio, Inc. BiotechnologyHealth Technology resTORbio, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the development and commercialization of medicines for aging-related diseases and conditions. It offers an immunotherapy under the TORC1 program. The company was founded by Chen Schor and Joan Mannick on July 5, 2016 and is headquartered in Boston, MA. | Health Technology |
Adicet Therapeutics, Inc.
Adicet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Adicet Therapeutics, Inc. operates as a biopharmaceutical company focuses on the development of cell immunotherapies. It engages in the design and development of immunotherapies for cancer and other disease indications with a focus on novel universal immune cell therapies. The company was founded by Aya Jakobovits in 2014 and is headquartered in Beverly Hills, CA. | Health Technology |
ZS Pharma, Inc.
ZS Pharma, Inc. Pharmaceuticals: MajorHealth Technology ZS Pharma, Inc. engages in the development of development and commercialization of non-absorbed drugs to treat renal, cardiovascular, liver and metabolic diseases. It develops treatment of hyperkalemia. It also focuses on clinical development, novel technology, and clinical trials. The company was founded by Alvaro F. Guillem and Donald Jeffrey Keyser on February 5, 2008 and is headquartered in San Mateo, CA. | Health Technology |
InterMune, Inc.
InterMune, Inc. BiotechnologyHealth Technology InterMune, Inc. operates as a biotechnology company that researches, develops and commercializes therapies in pulmonology and orphan fibrotic diseases. It focuses on therapies for the treatment of idiopathic pulmonary fibrosis, a progressive and fatal lung disease. The firms research programs are focused on the discovery of targeted, small-molecule therapeutics and biomarkers to treat and monitor serious pulmonary and fibrotic diseases. The company was founded in 1998 and is headquartered in South San Francisco, CA. | Health Technology |
Global Blood Therapeutics, Inc.
Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir, and David R. Phillips in February 2011 and is headquartered in South San Francisco, CA. | Health Technology |
- Borsa valori
- Insiders
- Carrie Krehlik